Your browser doesn't support javascript.
loading
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth.
Doleschel, Dennis; Hoff, Sabine; Koletnik, Susanne; Rix, Anne; Zopf, Dieter; Kiessling, Fabian; Lederle, Wiltrud.
Afiliación
  • Doleschel D; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Hoff S; Research and Development, Preclinical Research Oncology, Bayer AG, Berlin, Germany.
  • Koletnik S; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Rix A; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Zopf D; Research and Development, Preclinical Research Oncology, Bayer AG, Berlin, Germany. dieter.zopf@nuvisan.com.
  • Kiessling F; Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Lederle W; Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany.
J Exp Clin Cancer Res ; 40(1): 288, 2021 Sep 13.
Article en En | MEDLINE | ID: mdl-34517894
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Piridinas / Neoplasias Colorrectales / Receptor de Muerte Celular Programada 1 / Inmunoterapia Idioma: En Revista: J Exp Clin Cancer Res Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Piridinas / Neoplasias Colorrectales / Receptor de Muerte Celular Programada 1 / Inmunoterapia Idioma: En Revista: J Exp Clin Cancer Res Año: 2021 Tipo del documento: Article